©Author(s) (or their employer(s)) 2026.
World J Psychiatry. Mar 19, 2026; 16(3): 115163
Published online Mar 19, 2026. doi: 10.5498/wjp.v16.i3.115163
Published online Mar 19, 2026. doi: 10.5498/wjp.v16.i3.115163
Table 1 Sociodemographic and clinical characteristics of schizophrenia patients and healthy controls, n (%)/mean ± SD
| Patients (n = 77) | Healthy controls (n = 55) | t/χ² | P value | |
| Age (years) | 35.19 ± 10.50 | 38.69 ± 11.72 | -1.796 | 0.075 |
| Sex (male/female) | 38/39 | 27/28 | 0.001 | 0.977 |
| Body mass index (kg/m2) | 25.10 ± 4.80 | 24.90 ± 3.92 | 0.255 | 0.799 |
| Education (years) | 10.12 ± 2.83 | 13.22 ± 3.41 | -5.694 | < 0.001 |
| Smoking status | 18 (23.4) | 15 (27.3) | 0.260 | 0.610 |
| Age of onset (years) | 25.42 ± 5.62 | - | - | - |
| Duration of illness (years) | 7.0 (3.0, 15.50) | - | - | - |
| Equivalent dose of chlorpromazine (mg/day) | 663.10 ± 279.63 | - | - | - |
- Citation: Xu L, Zhang XB, Luan LS, Yang M, Zhang J, Yang HD, Tang XW. Electroconvulsive therapy alters serum cytokine levels and correlates with symptom improvement in patients with acute schizophrenia. World J Psychiatry 2026; 16(3): 115163
- URL: https://www.wjgnet.com/2220-3206/full/v16/i3/115163.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i3.115163